The influence of genetic features on the psychological status of patients who suffered from a myocardial infarction (literature review)
- Authors: Golovenkin S.E1, Nikulina S.Y.1, Bubnova M.G2, Orlova Y.V1, Maksimov V.N3
-
Affiliations:
- Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky of the Ministry of Healthcare of Russia
- National Medical Research Center of Therapy and Preventive Medicine of the Ministry of Healthcare of Russia
- Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences
- Issue: Vol 7, No 9 (2021)
- Pages: 104-112
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/288642
- DOI: https://doi.org/10.18565/therapy.2021.9.104-112
- ID: 288642
Cite item
Abstract
Full Text
About the authors
S. E Golovenkin
Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky of the Ministry of Healthcare of Russia
Email: gse2008@mail.ru
660014, Krasnoyarsk, 12 Instrumentalnaya Str. Tel.: +7 (904) 890-35-42
S. Yu Nikulina
Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky of the Ministry of Healthcare of Russia
Email: nicoulina@mail.ru
660014, Krasnoyarsk, 12 Instrumentalnaya Str. Tel.: +7 (908) 212-53-79
M^. G Bubnova
National Medical Research Center of Therapy and Preventive Medicine of the Ministry of Healthcare of Russia
Email: mbubnova@gnicpm.ru
101990, Moscow, 10 Petroverigsky Lane. Tel.: +7 (903) 752-21-86
Yu. V Orlova
Krasnoyarsk State Medical University named after professor V.F. Voino-Yasenetsky of the Ministry of Healthcare of Russia
Email: juliann303@yandex.ru
660014, Krasnoyarsk, 12 Instrumentalnaya Str
V. N Maksimov
Research Institute of Therapy and Preventive Medicine - a branch of Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences
Email: medik11@mail.ru
630089, Novosibirsk, 175/1 Borisa 112 Bogatkova Str. Tel.: +7 (913) 903-44-89
References
- Naghavi M., Wang H., Lozano R. et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015; 385(9963): 117-71. doi: 10.1016/S0140-6736(14)61682-2.
- Бойцов С.А., Погосова Н.В., Бубнова М.Г с соавт. Кардиоваскулярная профилактика 2017. Российские национальные рекомендации. Российский кардиологический журнал. 2018; 6: 7-122. @@Boitsov S.A., Pogosova N.V., Bubnova M.G. et al. Cardiovascular prevention 2017. National guidelines. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2018; 6: 7-122 (In Russ.). https://dx.doi.org/10.15829/1560-4071-2018-6-7-122.
- Аронов Д.М., Бубнова М.Г, Барбараш О.Л. с соавт. Острый инфаркт миокарда с подъемом сегмента ST электрокардиограммы: реабилитация и вторичная профилактика. Российские клинические рекомендации. CardioСоматика. 2014; S1: 5-41. @@Aronov D.M., Bubnova M.G., Barbarash O.L. et al. Acute myocardial infarction with ST segment elevation electrocardiograms: rehabilitation and secondary prevention. Russian clinical guidelines. CardioSomatica. 2014; S1: 5-41 (In Russ.).
- Демографический ежегодник России. 2015: Статистический сборник Росстата. M. 2015; 263 c. @@Demographic yearbook of Russia. 2015: Statistical collection of Rosstat. Moscow. 2015; 263 pp. (In Russ.).
- Аронов Д.М. История развития кардиореабилитации в России. Кардиология. 2018; S11: 14-21. @@Aronov D.M. History of cardiac rehabilitation in Russia. Kardiologiya = Cardiology. 2018; S11: 14-21 (In Russ.). https://dx.doi.org/10.18087/cardio.2604.
- Аронов Д.М., Бубнова М.Г. Проблемы внедрения новой системы кардиореабилитации в России. Российский кардиологический журнал. 2013; 4: 14-22. @@Aronov D.M., Bubnova M.G. Challenges of the implementation of a new cardiac rehabilitation system in Russia. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2013; 4: 14-22 (In Russ.). https://dx.doi.org/10.15829/1560-4071-2013-4-14-22.
- O'Gara P.T., Kushner F.G., Ascheim D.D. еt al. ACCF/AHA guidelines for the management of ST-elevation myocardial infarction. A report of the American College of Cardiology Foundation/American Heart Association. Task force on practice guidelines. J Am Coll Cardiol. 2011; 61(4): e78-e140. doi: 10.1016/j.jacc.2012.11.019.
- Steg G., James S.K., Atar D. et al. ESC Guidelines for the management of acute myocardial Infarction in patients presenting with ST-segment elevation. Task force on management of elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J. 2012; 33(20): 2569-619. doi: 10.1093/eurheartj/ehs215.
- Levine G.N., Bates E., Blankenship J.C. et al. ACC/AHA/SCAI 2011 guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association. Task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011; 58(24): e44-122. doi: 10.1016/j.jacc.2011.08.007.
- Wijns W., Kolh P., Danchin N. et al. Guidelines on myocardial revascularization. ESC/EACTS guidelines. Eur Heart J. 2010; 31(20): 2501-55. doi: 10.1093/eurheartj/ehq277.
- Taylor R.S., Brown A., Ebrahim S. et al. Exercise-based rehabilitation for patients with coronary heart disease: review and metaanalysis of randomized controlled trials. Am J Med. 2004; 116(10): 682-92. doi: 10.1016/j.amjmed.2004.01.009.
- de Vries H., Kemps H.M.C., van Engen-Verheul M.M. et al. Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. Eur Heart J. 2015; 36(24): 1519-28. doi: 10.1093/eurheartj/ehv111.
- De Schutter A., Kachur S., Lavie C.J. et al. Cardiac rehabilitation fitness changes and subsequent survival. Eur Heart J Qual Care Clin Outcomes. 2018; 4(3): 173-79. doi: 10.1093/ehjqcco/qcy018.
- Doimo S., Fabris E., Piepoli M. et al. Impact of ambulatory cardiac rehabilitation on cardiovascular outcomes: A long-term follow-up study. Eur Heart J. 2019; 40(8): 678-85. doi: 10.1093/eurheartj/ehy417.
- Аронов Д.М. Кардиореабилитация больных ИБС: рецепт для России. Лечащий врач. 2007; 3: 22-26. @@Aronov D.M. Cardiorehabilitation of patients with coronary heart disease: a recipe for Russia. Lechashchiy vrach = Attending Physician. 2007; 3: 22-26 (In Russ.).
- Grace S., Chessex C., Arthur H. et al. Systematizing inpatient referral to cardiac rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Society joint position paper. J Cardiopulm Rehabil Prev. 2011; 31(3): E1-8. doi: 10.1097/ HCR.0b013e31829721f.
- Ades P.A., Keteyian S.J., Wright J.S. et al. Increasing cardiac rehabilitation participation from 20% to 70%: A road map from the Million Hearts Cardiac Rehabilitation Collaborative. Mayo Clin Proc. 2017; 92(2): 234-42. doi: 10.1016./j.mayocp.2016.10.014.
- Turk-Adawi K.I., Oldridge N.B., Tarima S.S. et al. Cardiac rehabilitation enrollment among referred patients. Рatient and organizational factors. J Cardiopulm Rehabil Prev. 2014; 34(2): 114-22. doi: 10.1097/HCR.0000000000000017.
- Endo N., Goto A., Suzuki T. et al. Factors associated with enrollment and adherence in outpatient cardiac rehabilitation in Japan. J Cardiopulm Rehabil Prev. 2015; 35(3): 186-92. doi: 10.1097/HCR.0000000000000103.
- Бубнова М.Г Актуальные проблемы участия и обучения кардиологических пациентов в программах кардиореабилитации и вторичной профилактики. Кардиоваскулярная терапия и профилактика. 2020; 6: 2649. @@Bubnova M.G. Relevant problems of participation and education of patients in cardiac rehabilitation and secondary prevention programs. Kardiovaskulyarnaya terapiya i profilaktika = Cardiovascular Therapy and Prevention. 2020; 6: 2649 (In Russ.). https://doi.org/10.15829/1728-8800-2020-2649.
- Аронов Д.М., Бубнова М.Г., Драпкина О.М. Немедикаментозная терапия больных с сердечно-сосудистыми заболеваниями в программах кардиореабилитации. Профилактическая медицина. 2020; 6-2: 57-64. @@Aronov D.M., Bubnova M.G., Drapkina O.M. www.rnmot.ru Non-pharmacological therapy of patients with cardiovascular diseases in cardiac rehabilitation programs. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine. 2020; 6-2: 57-64 (In Russ.). https://doi.org/10.17116/profmed20202306257.
- Menezes A.R., Lavie C.J., Milani R.V. et al. Cardiac rehabilitation in the United States. Prog Cardiovasc Dis. 2014; 56(5): 522-29. doi: 10.1016/j.pcad.2013.09.018.
- Bustamante M.J., Valentino G., Kramer V. et al. Patient adherence to a cardiovascular rehabilitation program: What factors are involved? Int J Clin Med. 2015; 6(9): 605-14. doi: 10.4236/ijcm.2015.69081.
- Soroush A., Heydarpour B., Komasi S. et al. Barriers for the referral to outpatient cardiac rehabilitation: A predictive model including actual and perceived risk factors and perceived control. Ann Card Anaesth. 2018; 21(3): 249-54. doi.10.4103/aca.ACA_87_17.
- Cortes-Beringola A., Fitzsimons D., Pelliccia A. et al. Planning secondary prevention: Room for improvement. Eur J Prev Cardiol. 2017; 24(3S): 22-28. doi: 10.1177/2047487317704954.
- Fumeron F., Betoulle D., Nicaud V. et al. Serotonin transporter gene polymorphism and myocardial infarction: Etude Cas-Temoins de l'lnfarctus du Myocarde (ECTIM). Circulation. 2002; 105(25): 2943-45. doi: 10.1161/01.cir.0000022603.92986.99.
- Nakatani D., Sato H., Sakata Y. et al. Influence of serotonin transporter gene polymorphism on depressive symptoms and new cardiac events after acute myocardial infarction. Am Heart J. 2005; 150(4): 652-58. doi: 10.1016/j.ahj.2005.03.062.
- Голимбет В.Е., Волель Б.А., Должиков А.В., Исаева М.И. Исследование роли полиморфизма 5-HTTLPR гена переносчика серотонина в развитии депрессии при ишемической болезни сердца. Журнал неврологии и психиатрии им. C.C. Корсакова. 2012; 8: 63-69. @@Golimbet V.E., Volel' B.A., Dolzhikov A.V., Isaeva M.I. The role of the 5-HTTLPR polymorphism of the serotonin transporter gene in the development of depression in patients with coronary heart disease. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova = Journal of Neurology and Psychiatry named after S.S. Korsakov. 2012; 8: 63-69 (In Russ.).
- Zhang L.J., Zeng X.T., Zhao M.J. et al. The important effect of 5-HTTLPR polymorphism on the risk of depression in patients with coronary heart disease: a meta-analysis. BMC Cardiovasc Disord. 2020; 20(1):141. doi: 10.1186/s12872-020-01424-1.
- Meyer T., Rothe I., Staab J. et al. SPIRR-CAD Investigators. Length polymorphisms in the angiotensin I-converting enzyme gene and the serotonin-transporter-linked polymorphic region constitute a risk haplotype for depression in patients with coronary artery disease. Biochem Genet. 2020; 58(4): 631-48. doi: 10.1007/s10528-020-09967-w.
- Liu Y.Q., Su G.B., Duan C.H. et al. Brain-derived neurotrophic factor gene polymorphisms are associated with coronary artery disease-related depression and antidepressant response. Mol Med Rep. 2014; 10(6): 3247-53. doi: 10.3892/mmr.2014.2638.
- Amadio P., Colombo G.I., Tarantino E. et al. BDNFVal66met polymorphism: a potential bridge between depression and thrombosis. Eur Heart J. 2017; 38(18): 1426-35. doi: 10.1093/eurheartj/ehv655.
- Kang H.J., Bae K.Y., Kim S.W. et al. BDNF val66met polymorphism and depressive disorders in patients with acute coronary syndrome. J Affect Disord. 2016; 194: 1-8. doi: 10.1016/j.jad.2016.01.033.
- Westermair A.L., Munz M., Schaich A. et al. Association of genetic variation at AQP4 locus with vascular depression. Biomolecules. 2018; 8(4): 164. doi: 10.3390/biom8040164.
- Zhang X., Huo Q., Sun W. et al. Rs2910164 in microRNA-146a confers an elevated risk of depression in patients with coronary artery disease by modulating the expression of NOS1. Mol Med Rep. 2018; 18(1): 603-09. doi: 10.3892/mmr.2018.8929.
- Dai Z., Li Q., Yang G. et al. Using literature-based discovery to identify candidate genes for the interaction between myocardial infarction and depression. BMC Med Genet. 2019; 20(1): 104. doi: 10.1186/s12881-019-0841-8.
- Brandt J., Warnke K., Jorgens S. et al. Association of FKBP5 genotype with depressive symptoms in patients with coronary heart disease: A prospective study. J Neural Transm (Vienna). 2020; 127(12): 1651-62. doi: 10.1007/s00702-020-02243-6.
- Khandaker G.M., Zuber V., Rees J.M.B. et al. Shared mechanisms between coronary heart disease and depression: Findings from a large UK general population-based cohort. Mol Psychiatry. 2020; 25(7): 1477-86. doi: 10.1038/s41380-019-0395-3. Epub 2019 Mar 19. Erratum in: Mol Psychiatry. 2020 Aug 17.
- Han W., Wei Z., Dang R. et al. Angiotensin-II and angiotensin-(1-7) imbalance affects comorbidity of depression and coronary heart disease. Peptides. 2020; 131: 170353. doi: 10.1016/j.peptides.2020.170353.
- Han W., Zhang H., Gong X. et al. Association of SGK1 polymorphisms with susceptibility to coronary heart disease in Chinese Han patients with comorbid depression. Front Genet. 2019; 10: 921. doi: 10.3389/fgene.2019.00921.
- Purves K.L., Coleman J.R.I., Meier S.M. et al. A major role for common genetic variation in anxiety disorders. Mol Psychiatry. 2020; 25(12): 3292-303. doi: 10.1038/s41380-019-0559-1.
- Hagenaars S.P., Coleman J.R.I., Choi S.W. et al. Genetic comorbidity between major depression and cardio-metabolic traits, stratified by age at onset of major depression. Am J Med Genet B Neuropsychiatr Genet. 2020; 183(6): 309-30. doi: 10.1002/ajmg.b.32807.
- Akosile W., Voisey J., Lawford B. et al. The inflammasome NLRP12 is associated with both depression and coronary artery disease in Vietnam veterans. Psychiatry Res. 2018; 270: 775-79. doi: 10.1016/j.psychres.2018.10.051.
- Wang H., Ba Y., Han W. et al. Association of heat shock protein polymorphisms with patient susceptibility to coronary artery disease comorbid depression and anxiety in a Chinese population. Peer J. 2021; 9: e11636. doi: 10.7717/peerj.11636.
- Otte C., Wust S., Zhao S. et al. Glucocorticoid receptor gene and depression in patients with coronary heart disease: The Heart and Soul Study-2009 Curt Richter Award Winner. Psychoneuroendocrinology. 2009; 34(10): 1574-81. doi: 10.1016/j.psyneuen.2009.08.016.
- Alghamdi J., Matou-Nasri S., Alghamdi F. et al. Risk of neuropsychiatric adverse effects of lipid-lowering drugs: A Mendelian randomization study. Int J Neuropsychopharmacol. 2018; 21(12): 1067-75. doi: 10.1093/ijnp/pyy060.